期刊文献+

免疫缺陷患者侵袭性肺曲霉病的临床分析 被引量:3

Clinical analysis of invasive pulmonary aspergillosis in immunodeficient patients
下载PDF
导出
摘要 目的总结免疫缺陷患者侵袭性肺曲霉病(IPA)的临床特征,加深临床医师对IPA的认识。方法回顾性分析2015年1月—2019年3月在浙江大学医学院附属第一医院住院的101例IPA患者的临床资料。将患者分为粒细胞缺乏组、实体器官移植组、慢性阻塞性肺疾病组、结缔组织病组、慢性肾病组。比较各组的临床特点和影像学特征。结果粒细胞缺乏组有发热症状的患者比例多于慢性阻塞性肺疾病组,慢性阻塞性肺疾病组中咯痰、气促的患者比例多于其他各组。CT影像晕征在粒细胞缺乏组多见。结论免疫缺陷患者侵袭性肺曲霉感染的临床特征与基础疾病相关,影像学特点表现为结节团块影及晕征,但在慢性阻塞性肺疾病中不典型。 Objective To summarize the clinical features of invasive pulmonary aspergillosis(IPA)in immunodeficient patients and to deepen the understanding of IPA among clinicians.Methods The clinical data of 101 IPA patients who were hospitalized in the First Affiliated Hospital,School of Medicine,Zhejiang University from January 2015 to March 2019 were retrospectively analyzed.The patients were assigned to different groups based on the presence of neutropenia,solid organ transplantation,chronic obstructive pulmonary disease(COPD),connective tissue disease,or chronic kidney disease.The clinical and imaging characteristics were compared between patient groups.Results Higher proportion of neutropenic patients had fever than the COPD patients.Higher proportion of COPD patients had cough and shortness of breath than other patients.Cavity lesions were more common in the patients with COPD or chronic kidney disease.Halo sign was more common in the neutropenic patients.Conclusions The clinical features of IPA are related to the underlying diseases in immunodeficiency patients.Nodular mass and halo sign are primary imaging features of IPA,but atypical in COPD patients.
作者 胡小燕 周华 符一骐 陆明 周建英 HU Xiaoyan;ZHOU Hua;FU Yiqi;LU Ming;ZHOU Jianying(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou 310003,China)
出处 《中国感染与化疗杂志》 CAS CSCD 北大核心 2021年第4期394-398,共5页 Chinese Journal of Infection and Chemotherapy
基金 杭州市医药卫生科技项目(OO20190746)。
关键词 免疫缺陷 侵袭性肺曲霉病 临床特点 immunodeficiency invasive pulmonary aspergillosis clinical feature
  • 相关文献

参考文献4

二级参考文献30

  • 1Chakrabarti A,Chatterjee SS, Das A, et al. Invasive aspergillosis in developing countries [ J ]. Med Myco1,2011,49 ( Suppl 1 ) : S35-S47.
  • 2Marchetti O, Lamoth F, Mikulska M, et al. European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and henaatopoietic SCT recipients [ J ]. Bone Marrow Transplant, 2012, 47 ( 6 ) : 846-854.
  • 3Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease[ J]. Eur RespirJ,2007,30(4) :782-800.
  • 4Guinea J, Torres-Narbona M, Gij6n P, et al. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome [ J ]. Clin Microbiol Infect, 2010,16 (7) : 870-877.
  • 5XuH, Li L, Huang WJ, Wang LX, et al. Invasive pulmonary asper- gillosis in patients with chronic obstructive pulmonary disease: a case control study from China [ J ]. Clin Microbiol Infect, 2012,18 (4) :403-408.
  • 6Vestbo J, Hurd SS, AgnstI AG, et al. Global strategy for the diagno- sis, management, and prevention of ehronie obstructive pulmonary disease: GOLD executive summary [ J ]. Am J Respir Crit Care Med,2013,187(4) :347-365.
  • 7Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria [ J ]. Clin Infect Dis ,2008,47 (5) :674-683.
  • 8Leav BA, Fanburg B, Hadley S. Invasive pulmonary aspergillosis associated with higla-dose inhaled flutieasone [ J ]. N Engl J Med, 2000,343 ( 8 ) :586.
  • 9He H, Ding L, Li F, et al. Clinical features of invasive bronchial- pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study [ J]. Crit Care, 2011,15(1) :R5.
  • 10Metan G, Ko9 AN, Atalay A, et al. What should be the optimal cut-off of serum 1,3-f3-D-glucan for the detection of invasive pul- monary aspergillosis in patients with haematological malignancies? [ J]. Mycoses,2013,56 ( 1 ) :34-38.

共引文献588

同被引文献23

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部